2026
PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy
Autophagy, 22(1):121–144
Refereed journals
2024
Association of RNF43 genetic alterations with BRAF V600E and MSI-high in colorectal cancer
JCO Precision Oncology, 8:e2300411
2023
Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma
Journal of Hepatology, 78(3):614–626
2023
Mapping alternative polyadenylation in human cells using direct RNA sequencing technology
STAR Protocols, 4(3):102420
2021
The co-mutational spectrum determines the therapeutic response in murine FGFR2 fusion-driven cholangiocarcinoma
Hepatology, 74(3):1357–1370
2013
Tetracycline and glutathione inhibit matrix metalloproteinase activity: an in vitro study using culture supernatants of L929 and Dalton lymphoma cell lines
Journal of Cancer Research, 2013:328134
Presentations
Invited talks & conference proceedings
Invited talk
“Precision Medicine: Solving the Puzzle of Cancer Treatment”
MolMedBio 2025 — Cancer Biology: From Mechanisms to Therapeutics, IIT Dharwad, 5–6 December 2025
Conference
Banerjee A, Bhutia SK, Das S, Kendre G. “Deciphering the role of inter-domain crosstalk in oral squamous cell carcinoma”
48th All India Cell Biology Conference and Symposium, December 2025
Conference
Kendre G, Marhenke S, Lorz G, Saborowski M, Vogel A, Saborowski A. “A murine model of FGFR2 fusion-driven intrahepatic cholangiocarcinoma…”
The International Liver Congress™ 2021 (EASL), Geneva, Switzerland; abstract in Journal of Hepatology 75(Suppl. 2)
Complete and up-to-date record
New work appears on Google Scholar and ORCID before this page is updated.
Scopus Author ID 57230963400